GPT HEALTHCARE LTD Q2 RESULTS
Q-comm audits; modest Q1 for IT firms
Happy Wednesday! Due to recent hygiene lapses by quick commerce, the government has intensified surprise inspections of their warehouses. This and more in today’s ETtech Morning Dispatch.
73% IPOs trading above issue price as primary market shines in H1, four turn multibaggers
The fundraising of Rs 26,272 crore, however fell short of the previous two years likely due to the absence of mega issues. Investors' reception also remained positive with only one failed IPO.
Q4 results: Stable costs boost India Inc. profits
Steady costs and firm domestic demand supported corporate performance in the March quarter.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
Apollo Hospitals Q4 Results: Net profit soars 77% YoY to Rs 258 crore; revenue jumps 15%
Apollo Hospitals Q4 Results: Revenue from operations for the January-March 2024 period increased 15% YoY to Rs 4,944 crore. The company's board has recommended a final dividend of Rs 10 per share for FY24. EBITDA for the fourth quarter stood at Rs 640 crore in the reporting March quarter, compared with Rs 488 crore in the same quarter a year earlier.
Google search results are being tampered to fraud you. Check how
Google search results can also be used as weapon for cyber fraud. Scamsters are reportedly using Artificial Intelligence (AI) to trick users.
- Go To Page 1
3M India Q4 Results: 'Post-it' maker posts profit rise; shares surge
3M INDIA-RESULTS/'Post-it' maker 3M India posts Q4 profit rise; shares surge
Q4 results today: ITC, IndiGo among 181 companies to announce earnings on Thursday
181 companies, including IndiGo and ITC, will announce their quarterly earnings for Jan-Mar 2024. IndiGo is expected to post healthy earnings, while ITC may see muted revenue growth.
Max Healthcare Institute Q4 Results: PAT down 3% YoY to Rs 311 crore
Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement.
Max Healthcare Q4 Results: Net profit drops 3% YoY to Rs 311 crore
Max Healthcare's Q4FY24 net profit dips 3% YoY to Rs 311 crore, attributed to lower effective tax rate in Q4FY23 and new unit losses. Gross revenue rises 15% YoY to Rs 1,890 crore.
Q4 results today: Sun Pharma, Nykaa, Paytm among 162 companies to declare earnings on Wednesday
162 companies to report Q4 earnings on Wednesday. Nykaa expects 24% BPC and Fashion GMV growth, while Paytm faces a revenue decline from RBI actions. Analysts also predict pressure from discounting and lower advertising income.
Global Health Q4 Results: Net profit rises 25% to Rs 127 crore
For the year ended on March 31, 2024, the company said its net profit increased to Rs 478 crore as against Rs 326 crore in FY23.
Mankind Pharma Q4 Results: Net profit jumps 62% YoY to Rs 477 crore
Mankind Pharma on Wednesday reported 62% year-on-year (YoY) jump in net profit to Rs 477 crore in Q4FY24 led by strong domestic formulation sales and one-off US export opportunities.
Do Dr Lal Pathlabs' results indicate a turnaround for the sector? 4 stocks from diagnostic space, 3 with upside potential of up to 31%
Some sectors have a company which can be called as the bell weather of that sector and that is why its results of that company probably are indicative of what is happening in the sector. In case of the diagnostic, it is probably the Dr Lals path labs which would fit the criteria, it has national presence, large network, present in both physical and digital segment. So when the quarterly numbers come and they show improvement on many fronts then probably it is time to have a look at them more seriously and see if there is a possible turnaround building in the sector. This became even more important because these stocks had gained extremely high valuation and also popularity in terms of both retail and institutional participation. But then for close to two years, they have been a strong under performer in a strong bull market. Does this result mean that finally in terms of price war for customer acquisition over and now the valuation readjustment will start in the upward direction.
Dr. LalPath Labs Q4 Reslts: Firm posts higher profit on healthy testing demand
Its shares climbed as much as 7.8% after the results before trimming some gains to trade up about 6%. Rival Metropolis Healthcare was up about 2% and Thyrocare Technologies gained about 1%.
Happiest Minds Tech Q4 Results: Profit jumps 25%, revenues up 10%
Happiest Minds Tech Q4 Results: For full year, the Bengaluru-headquartered firm’s profit rose 7.5% to Rs 248.39 crore from Rs 230.99 crore in FY23. Revenues increased 13.7% to Rs 1624.66 crore from Rs 1,429.29 crore last year.
Dabur Q4 Results Preview: PAT seen to grow at 9% YoY to Rs 320 crore on domestic revenue growth
Dabur India is expected to unveil a net profit ranging between Rs 313 crore to Rs 341 crore for Q4FY24. The estimates for profit after tax (PAT) hover between Rs 313 crore to Rs 341 crore, with Axis Securities forecasting the highest figure and Anand Rathi predicting the lowest. The upcoming report will shed light on crucial aspects such as EBITDA margins, international business expansion, and enhancements in operating profit margins (OPM).
GE HealthCare Q1 Results: Co misses quarterly revenue estimates on weakness in China market
GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market and weaker-than-expected demand for its scanning devices, sending its shares tumbling as much as 12% before the bell.
Deals, hiring show HCL Tech can tap expected IT bounce
Revenue in the major markets of the US and Europe grew sequentially by 4.2% and 2.3%, respectively, while major business verticals also showed higher revenue. But what sets HCLTech apart from peers is the fact that it continued to add headcount during the quarter.
LTIMindtree shares drop 2.5% after disappointing Q4 results. Should you buy?
On Thursday, shares of the IT service company LTIMindtree dipped 2.5% to touch the day's low at Rs 4,611 on the BSE, as the company's Q4 results failed to meet market expectations.
Wipro Q4 Results: Profit falls 8% YoY to Rs 2,835 crore, marginally misses estimates
Wipro Q4 Results: Wipro reported an 8% YoY decrease in net profit to Rs 2,835 crore for the quarter ended March 2024. PAT is slightly below estimates. Operating margins at 16.4%. Future outlook optimistic with a focus on AI transformation.
Wipro Q4 Results Preview: Muted show likely once again, all eyes on new CEO’s growth roadmap
Wipro Q4 Results Preview: The company is projected to see its consolidated revenue remain stagnant compared to the previous quarter and decrease by 4.3% year-on-year (YoY) to Rs 22,185 crore, based on the average estimates provided by 10 brokerage firms.
Fortis Healthcare Q3 Results: Net profit drops 11% YoY to Rs 134 crore
The operating earnings before interest, tax, depreciation and amortisation (EBITDA) rose 6.8% YoY to Rs 284 crore. The EBITDA margins declined 80 basis points to 16.9%.
Metropolis Healthcare Q3 Results: Net profit drops 25% to Rs 27 crore
"The performance in Q3 was marginally impacted on account of heavy rainfall and floods in Chennai and adjacent areas in December 2023, leading to loss of revenues for approx. 7-8 days from Chennai region, which is one of the focus cities for Metropolis," Ameera Shah, promoter and managing director of Metropolis Healthcare said.
Q2 Results on Friday: What to expect from M&M, Coal India, LIC and Hindalco
Among index majors, Coal India, Eicher Motors, Hindalco Industries, Mahindra & Mahindra, and Oil and Natural Gas Corp are set to release their quarterly numbers.
HealthCare Global Enterprises Q2 Results: Net profit jumps 84% YoY to Rs 14 crore
Earnings before interest, tax, depreciation and ammortisation (EBITDA) gained 13% YoY to Rs 85 crore in Q2FY24. The EBITDA margin dripped 40 basis points YoY to 17.4%.
Max Healthcare Q2 Results: Net profit zooms 26% YoY to Rs 338 crore
The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 21% YoY to Rs 497 crore. The EBITDA margin improved 100 basis points YoY to 28.7%.
Max Healthcare Institute Q2 Results: Profit rises 27% YoY to Rs 338 crore
The company said all hospitals improved their average revenue per operating bed (ARPOB) during the period and the overall average growth in ARPOB stood at 13 per cent year-on-year (YoY). During the quarter, international patient revenue grew by 25 per cent as compared to the year-ago period, and the share of international patient revenues stood at 9 per cent of the hospital revenue during the quarter, it added.
268 companies set to release Q2 results on Monday. What to expect from Nykaa, Divi’s Labs and Varun Beverages
Max Healthcare Institute, NHPC, Bharat Forge, Hindustan Petroleum Corporation, Gland Pharma, Emami, Exide Industries, R R Kabel, Bajaj Electricals, Bikaji Foods International, Sun Pharma Advanced Research, Sobha Ltd, Ujjivan Financial Services, Quess Corp, Fusion MicroFinance, Gateway Distriparks, Heidelberg Cement, Va Tech Wabag, and Paras Defence and Space Technologies are among the other major companies releasing results on Monday.
Load More
